Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Step by step instructions to Figure out the Natural Effect of 5G Pinnacles - 26 Well known Nissan Vehicles in the U.S.
- 3Brazilian cardinal orders a popular Catholic priest to go offline following right-wing attacks
- 4Journeys That could only be described as epic: Delightful Voyage Lines All over the Planet
- 5Audits of the Top Science fiction Movies This Year
- When darkness shines: How dark stars could illuminate the early universe
- As cases of a rare, deadly infection rise, doctors worry fewer teens will get vaccinated
- Seven deaths possibly linked to malfunctioning glucose monitors
- How to avoid or deal with an outrageous medical bill
- Spanish police and soldiers track boars, reinforce farm security amid swine fever outbreak
- Journalist reported killed in the Gaza Strip
- Eurovision Song Contest changes voting rules after controversial allegations against Israel
- Bayer sues COVID vaccine makers over mRNA technology
- 10 Asian Countries Perfect for Solo Female Travelers
